Get started
Author

Anne Vinther Morant

Observed names: Anne V. Morant, Morant, Anne Vinther
Institution: Lundbeck (Denmark)
ORCID: 0000-0002-4742-7621
Observed ORCID: 0000-0002-4742-7621
OpenAlex ID: A5055935356
β-Glucosidases as detonators of plant chemical defense
2008 · Anne Vinther Morant, Kirsten Jørgensen, et al. · Phytochemistry · 573
Cyanogenic glycosides: a case study for evolution and application of cytochromes P450
2006 · Søren Bak, Susanne Michelle Paquette, et al. · Phytochemistry Reviews · 143
Biosynthesis of the Cyanogenic Glucosides Linamarin and Lotaustralin in Cassava: Isolation, Biochemical Characterization, and Expression Pattern of CYP71E7, the Oxime-Metabolizing Cytochrome P450 Enzyme
2010 · Kirsten Jørgensen, Anne Vinther Morant, et al. · PLANT PHYSIOLOGY · 119
PDF
The β -Glucosidases Responsible for Bioactivation of Hydroxynitrile Glucosides in Lotus japonicus
2008 · Anne Vinther Morant, Nanna Bjarnholt, et al. · PLANT PHYSIOLOGY · 76
Technology-Enabled Assessment of Functional Health
2018 · Diane J. Cook, Maureen Schmitter-Edgecombe, et al. · IEEE Reviews in Biomedical Engineering · 59
Lessons learned from metabolic engineering of cyanogenic glucosides
2007 · Anne Vinther Morant, Kirsten Jørgensen, et al. · Metabolomics · 40
Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders
2019 · Anne Vinther Morant, Vivien Jagalski, et al. · Frontiers in Medicine · 31
PDF
US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development
2020 · Anne Vinther Morant, Henrik Tang Vestergaard, et al. · Clinical and Translational Science · 30
PDF
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016
2019 · Anne Vinther Morant, Vivien Jagalski, et al. · Clinical and Translational Science · 23
PDF
European Marketing Authorizations Granted Based on a Single Pivotal Clinical Trial: The Rule or the Exception?
2017 · Anne Vinther Morant, Henrik Tang Vestergaard · Clinical Pharmacology & Therapeutics · 22
Cyanogenic glycosides: a case study for evolution and application of cytochromes P450
2007 · Søren Bak, Susanne Michelle Paquette, et al. · Phytochemistry Reviews · 10
PDF
New Drug and Biologics Approvals in 2019: A Systematic Analysis of Patient Experience Data in FDA Drug Approval Packages and Product Labels
2020 · Katrine Schultz-Knudsen, Ugne Sabaliauskaite, et al. · Therapeutic Innovation & Regulatory Science · 8
PDF
ChemInform Abstract: β‐Glucosidases as Detonators of Plant Chemical Defense
2008 · Anne Vinther Morant, Kirsten Joergensen, et al. · ChemInform · 1
Regulatory approvals based on a single pivotal trial (2017-2019): Characteristics and use of supportive evidence
2020 · Katrine Schultz-Knudsen, Anne Vinther Morant, et al.
Regulatory approvals based on a single pivotal trial (2017-2019): Characteristics and use of supportive evidence
2020 · Katrine Schultz-Knudsen, Henrik Tang Vestergaard, et al.
The cassava oxime metabolizing cytochrome P450 in cyanogenic glucoside biosynthesis
2007 · Anne Vinther Morant, Marc Morant, et al. · Research at the University of Copenhagen (University of Copenhagen)
Cellular localization of biosynthesis and breakdown of cyanogenic glucosides in Lotus japonicus
2006 · Morant, Anne Vinther, Dam, Winnie, et al. · Research at the University of Copenhagen (University of Copenhagen)
The cassava oxime metabolizing P450 in cyanogenic glucoside biosynthesis
2006 · Morant, Anne Vinther, Morant, Marc, et al. · Research at the University of Copenhagen (University of Copenhagen)
Works count: 18
Citation count: 1,135
H-index: 10
I10-index: 11
Year
Topic
Type